{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:28:29Z","timestamp":1783942109210,"version":"3.55.0"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.2169\/internalmedicine.9838-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:21:20Z","timestamp":1515622880000},"page":"1503-1508","source":"Crossref","is-referenced-by-count":24,"title":["An Overview of Kidney Disease Following Hematopoietic Cell Transplantation"],"prefix":"10.2169","volume":"57","author":[{"given":"Minoru","family":"Ando","sequence":"first","affiliation":[{"name":"Department IV of Internal Medicine, Tokyo Women's Medical University, Japan"},{"name":"Department of Medicine, Tokyo Metropolitan Fuchu Medical and Welfare Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Humphreys BD, Soiffer RJ, Magee CC. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 16: 151-161, 2005.","DOI":"10.1681\/ASN.2004100843"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med 374: 2256-2267, 2016.","DOI":"10.1056\/NEJMra1404711"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bodge MN, Reddy S, Thompson MS, Savani BN. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations. Biol Blood Marrow Transplant 20: 908-919, 2014.","DOI":"10.1016\/j.bbmt.2014.02.013"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miralbell R, Bieri S, Mermillod B, et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 14: 579-585, 1996.","DOI":"10.1200\/JCO.1996.14.2.579"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zager RA, O'Quigley J, Zager BK, et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13: 210-216, 1989.","DOI":"10.1016\/S0272-6386(89)80054-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Parikh CR, McSweeney PA, Korular D, et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62: 566-573, 2002.","DOI":"10.1046\/j.1523-1755.2002.00455.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ando M, Mori J, Ohashi K, et al. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT. Bone Marrow Transplant 45: 1427-1434, 2010.","DOI":"10.1038\/bmt.2009.377"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mori J, Ohashi K, Yamaguchi T, et al. Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on acute kidney injury network criteria. Intern Med 51: 2105-2110, 2012.","DOI":"10.2169\/internalmedicine.51.7418"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 1: 685-694, 2006.","DOI":"10.2215\/CJN.00380705"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Terrier B, Delmas Y, Hummel A, et al. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant 22: 1369-1376, 2007.","DOI":"10.1093\/ndt\/gfl795"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pilar F, Lourdes V, Dolores C, et al. Chronic graft-versus-host disease of the kidney in patients with allogeneic hematopoietic stem cell transplant. Eur J Haematol 91: 129-134, 2013.","DOI":"10.1111\/ejh.12149"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ellis MJ, Parikh CR, Inrig JK, Kambay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 8: 2378-2390, 2008.","DOI":"10.1111\/j.1600-6143.2008.02408.x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Choi M, Sun G-L, Kurian S, et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 113: 1580-1587, 2008.","DOI":"10.1002\/cncr.23773"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Abboud I, Porcher R, Robin M, et al. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15: 1251-1257, 2009.","DOI":"10.1016\/j.bbmt.2009.05.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Singh N, McNeely J, Parikh S, Bhinder A, Rovin BH, Shidham G. Kidney complication of hematopoietic cell transplantation. Am J Kidney Dis 61: 809-821, 2013.","DOI":"10.1053\/j.ajkd.2012.09.020"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Cohen EP. Renal failure after bone-marrow transplantation. Lancet 357: 6-7, 2001.","DOI":"10.1016\/S0140-6736(00)03561-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cohen EP, Krzesinski J-M, Launay-Vacher V, Sprangers B. Onco-nephrology: core curriculum 2015. Am J Kidney Dis 66: 869-883, 2015.","DOI":"10.1053\/j.ajkd.2015.04.042"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ando M. The need for 'onco-nephrology' is increasing in hematopoietic stem cell transplantation. Bone Marrow Transplant 51: 767-768, 2016.","DOI":"10.1038\/bmt.2016.68"},{"key":"19","unstructured":"19. The Japanese data center for hematopoietic cell transplantation [Internet]. [cited 2017 Oct. 25]. Available from: http:\/\/www.jdchct.or.jp\/en\/data\/slide\/2016."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shingai N, Morito T, Najima Y, et al. Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients. Bone Marrow Transplant 50: 1557-1562, 2015.","DOI":"10.1038\/bmt.2015.188"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Imai H, Oyama Y, Miura AB, Endoh M, Sakai H. Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 36: 474-480, 2000.","DOI":"10.1053\/ajkd.2000.9787"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Momoki K, Yamaguchi T, Ohashi K, Ando M, Nitta K. Emergence of dipstick proteinuria predicts overt nephropathy in patients following stem cell transplantation. Nephron 135: 31-38, 2017.","DOI":"10.1159\/000450798"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ando M, Ohashi K, Akiyama H, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 25: 278-282, 2010.","DOI":"10.1093\/ndt\/gfp485"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cohen EP. Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 39: 571-572, 2007.","DOI":"10.1038\/sj.bmt.1705643"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Schrier RW, Parikh CR. Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation. Nephrol Dial Transplant 20: 678-683, 2005.","DOI":"10.1093\/ndt\/gfh720"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Honda K, Ando M, Tsubokura M, Yamashita T, Akiyama H, Sakamaki H. An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation. CEN Case Rep 3: 34-39, 2014.","DOI":"10.1007\/s13730-013-0080-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shingai N, Morito T, Najima Y, et al. Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 20: 2010-2014, 2014.","DOI":"10.1016\/j.bbmt.2014.08.022"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Taghizadeh-Ghehi M, Sarayani A, Ashouri A, Ataei S, Moslehi A, Hadjibabaie M. Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients. Ren Fail 37: 994-998, 2015.","DOI":"10.3109\/0886022X.2015.1040699"},{"key":"29","unstructured":"29. Garcia GP, Arroyo HC, Gomez TA, et al. Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplant 3: 357-362, 1988."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Morito T, Ando M, Kobayashi T, et al. New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function. Bone Marrow Transplant 48: 972-976, 2013.","DOI":"10.1038\/bmt.2012.271"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 17: 1995-2005, 2006.","DOI":"10.1681\/ASN.2006020118"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shimoi T, Ando M, Munakata W, et al. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT. Bone Marrow Transplant 48: 80-84, 2013.","DOI":"10.1038\/bmt.2012.85"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 69: 430-435, 2006.","DOI":"10.1038\/sj.ki.5000055"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Humphreys BD. Renal complications of hematopoietic stem cell transplantation. In: Cancer and the Kidney. Cohen E, Ed. Oxford University Press, Oxford, 2010.","DOI":"10.1093\/med\/9780199580194.003.0008"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ichida S, Okada K, Itoh M, et al. Bone marrow transplant nephropathy successfully treated with angiotensin-converting enzyme inhibitor. Clin Exp Nephrol 10: 78-81, 2006.","DOI":"10.1007\/s10157-005-0394-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Moulder JE, Fish BL, Cohen EP. ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr Pharm Des 9: 737-749, 2003.","DOI":"10.2174\/1381612033455422"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Berns JS, Rosner MH. Onco-nephrology: what the nephrologist needs to know about cancer and the kidney. Clin J Am Soc Nephrol 7: 1691, 2012.","DOI":"10.2215\/CJN.03240312"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/11\/57_9838-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T04:04:10Z","timestamp":1527912250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/11\/57_9838-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9838-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}